Related Experiment Videos
[Lymphangioleiomyomatosis]
G Iu Tramov1, M Iu Tramov, A G Iurin
1Saint Petersburg Pathology Bureau, 194354, Saint Petersburg.
Arkhiv Patologii
|July 17, 2001
Summary
Lymphangioleiomyomatosis (LAM) is a rare lung disease. This case highlights concurrent LAM with other smooth muscle tumors, leading to fatal respiratory and cardiac failure.
Area of Science:
- Pulmonary Medicine
- Oncology
- Pathology
Background:
- Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease characterized by the abnormal proliferation of smooth muscle cells.
- It primarily affects women and can occur sporadically or in association with Tuberous Sclerosis Complex.
- Concurrent occurrence with other smooth muscle neoplasms is uncommon.
Observation:
- A case report of a 24-year-old female with concurrent lymphangioleiomyomatosis (LAM) of the lungs, mediastinal and abdominal lymph nodes.
- The patient also presented with renal angiomyolipomas and a uterine leiomyoma.
- The patient experienced progressive respiratory and cardiac failure.
Findings:
- Post-mortem examination revealed smooth muscle cell proliferation in the bronchi, vessel walls, and interalveolar septum, consistent with LAM.
- The lung tissue showed characteristic honey-comb lung formation due to cystic destruction.
- The concurrent presence of multiple smooth muscle tumors (LAM, angiomyolipomas, leiomyoma) was confirmed.
Implications:
- This case underscores the potential for multi-organ involvement in LAM and associated smooth muscle tumors.
- It highlights the aggressive nature of LAM and its potential to cause fatal cardiorespiratory complications.
- Further research into the molecular mechanisms underlying concurrent smooth muscle neoplasms may offer new therapeutic targets.